Emmanuel J. Simons
Chief Executive Officer chez AKOUOS
Profil
Emmanuel J.
Simons is the founder.
He founded Akouos, Inc. in 2016 and currently holds the title of Chief Executive Officer.
Dr. Simons has a doctorate degree from Massachusetts Institute of Technology, an MBA from Harvard Business School, and an undergraduate degree from Harvard College.
Postes actifs de Emmanuel J. Simons
| Sociétés | Poste | Début |
|---|---|---|
| AKOUOS | Chief Executive Officer | 01/01/2016 |
Formation de Emmanuel J. Simons
| Massachusetts Institute of Technology | Doctorate Degree |
| Harvard Business School | Masters Business Admin |
| Harvard College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Akouos, Inc.
 Akouos, Inc. BiotechnologyHealth Technology Akouos, Inc. is a precision genetic medicine company, which engages in the development of precision genetic medicines to restore and preserve hearing in genetically-defined patient populations. The firm's lead product candidate, AK-OTOF, is a gene therapy for the treatment of hearing loss due to mutations in the OTOF gene. It develops targeted adeno-associated viral vector based gene therapies for sensorineural hearing loss, which results from dysfunction or damage to sensory cells and nerve fibers of the inner ear. The company was founded by Emmanuel J. Simons, William F. Sewell, Richard H. Smith, Luk H. Vandenberghe, and Michael J. McKenna on March 7, 2016 and is headquartered in Boston, MA. | Health Technology |
